Krystal Biotech, Inc. SEC filings KRYS
Krystal Biotech, Inc. has 513 filings in SEC EDGAR's recent list, going back to Jul 14, 2017. Its latest annual report, Form ARS, was filed on Apr 3, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 2, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Other events
|
Jul 21, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2026 | May 15, 2026 |
| 8-K | Current report | May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 17, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2025 | Dec 23, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 8-K |
Current report
Other events
|
Oct 22, 2025 | Oct 22, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 25, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 19, 2025 | May 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2025 | May 12, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 6, 2025 | May 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2025 | Apr 28, 2025 |
| 8-K | Current report | Feb 28, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 19, 2025 | Feb 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 18, 2024 | Dec 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2024 | May 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 8, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 7, 2023 | Aug 2, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 26, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2023 | May 23, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 19, 2023 | May 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Material agreement
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Results of operations
|
May 8, 2023 | May 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 24, 2023 | Apr 23, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2023 | Mar 6, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 17, 2022 | Nov 17, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 18, 2022 | Aug 18, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Auditor change
|
May 26, 2022 | May 24, 2022 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2022 | May 23, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2022 | May 20, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 28, 2022 | Mar 26, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 22, 2022 | Mar 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 28, 2022 | Feb 25, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 18, 2022 | Jan 18, 2022 |
| 8-K |
Current report
Material agreement
|
Dec 3, 2021 | Nov 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 29, 2021 | Nov 29, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2021 | Nov 8, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 16, 2021 | Sep 13, 2021 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Aug 19, 2021 | Mar 24, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2021 | Aug 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 2, 2021 | Aug 2, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 7, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 1, 2021 | Jul 1, 2021 |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2021 | May 21, 2021 |
| 8-K |
Current report
Results of operations
|
May 10, 2021 | May 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2021 | Mar 24, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 1, 2021 | Mar 1, 2021 |
| 8-K |
Current report
Material agreement
|
Feb 5, 2021 | Feb 2, 2021 |
| 8-K |
Current report
Material agreement, Results of operations
|
Feb 2, 2021 | Jan 29, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2021 | Jan 7, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 4, 2021 | Jan 4, 2021 |
| 8-K |
Current report
Material agreement
|
Dec 31, 2020 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2020 | Oct 1, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 1, 2020 | May 29, 2020 |
| 8-K |
Current report
Material agreement
|
May 21, 2020 | May 18, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Other events
|
May 13, 2020 | May 12, 2020 |
| 8-K |
Current report
Officer or director change
|
May 5, 2020 | Apr 29, 2020 |
| 8-K |
Current report
Results of operations
|
May 4, 2020 | May 4, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2020 | Mar 10, 2020 |
| 8-K |
Current report
Officer or director change
|
Feb 25, 2020 | Feb 25, 2020 |
| 8-K/A |
Amended current report
Results of operations
|
Nov 5, 2019 | Nov 4, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2019 | Nov 4, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2019 | Oct 29, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2019 | Aug 5, 2019 |
| 8-K |
Current report
Material agreement
|
Jun 27, 2019 | Jun 24, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 24, 2019 | Jun 24, 2019 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2019 | May 30, 2019 |
| 8-K |
Current report
Results of operations
|
May 10, 2019 | May 6, 2019 |
| 8-K |
Current report
Material agreement
|
Mar 13, 2019 | Mar 12, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2019 | Mar 12, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 7, 2019 | Mar 1, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2018 | Nov 5, 2018 |
| 8-K |
Current report
Other events
|
Oct 23, 2018 | Oct 23, 2018 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 19, 2018 | Oct 18, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2018 | Oct 15, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 17, 2018 | Aug 16, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 1, 2018 | May 31, 2018 |
| 8-K |
Current report
Officer or director change
|
May 9, 2018 | May 3, 2018 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2018 | May 7, 2018 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 14, 2017 | Nov 13, 2017 |
| 8-K |
Current report
Unregistered share sale
|
Nov 2, 2017 | Nov 1, 2017 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Sep 25, 2017 | Sep 19, 2017 |
Showing 113 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KRYS (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Pittsburgh, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1711279
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.